- Home
- APWC vs LVTX Comparison
APWC vs LVTX Comparison
Compare APWC & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APWC
- LVTX
- Stock Information
- Founded
- APWC 1996
- LVTX 2016
- Country
- APWC Taiwan
- LVTX Netherlands
- Employees
- APWC N/A
- LVTX N/A
- Industry
- APWC Telecommunications Equipment
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- APWC Industrials
- LVTX Health Care
- Exchange
- APWC Nasdaq
- LVTX Nasdaq
- Market Cap
- APWC 30.1M
- LVTX 30.0M
- IPO Year
- APWC 1997
- LVTX 2021
- Fundamental
- Price
- APWC $1.62
- LVTX $1.33
- Analyst Decision
- APWC
- LVTX Hold
- Analyst Count
- APWC 0
- LVTX 3
- Target Price
- APWC N/A
- LVTX $3.17
- AVG Volume (30 Days)
- APWC 5.1K
- LVTX 58.8K
- Earning Date
- APWC 03-31-2025
- LVTX 05-20-2025
- Dividend Yield
- APWC N/A
- LVTX N/A
- EPS Growth
- APWC N/A
- LVTX N/A
- EPS
- APWC 0.17
- LVTX N/A
- Revenue
- APWC $472,672,000.00
- LVTX $11,982,000.00
- Revenue This Year
- APWC N/A
- LVTX N/A
- Revenue Next Year
- APWC N/A
- LVTX N/A
- P/E Ratio
- APWC $9.55
- LVTX N/A
- Revenue Growth
- APWC 11.02
- LVTX 77.01
- 52 Week Low
- APWC $1.24
- LVTX $0.85
- 52 Week High
- APWC $2.02
- LVTX $3.20
- Technical
- Relative Strength Index (RSI)
- APWC 54.52
- LVTX 57.94
- Support Level
- APWC $1.55
- LVTX $1.03
- Resistance Level
- APWC $1.65
- LVTX $1.44
- Average True Range (ATR)
- APWC 0.08
- LVTX 0.09
- MACD
- APWC 0.01
- LVTX 0.02
- Stochastic Oscillator
- APWC 75.00
- LVTX 73.55
About APWC Asia Pacific Wire & Cable Corporation Ltd. (Bermuda)
Asia Pacific Wire & Cable Corp Ltd is a holding company. It is principally engaged in owning operating companies engaged in the power cable, telecommunication cable, enameled wire, and electronic cable industry. It also provides project engineering services to customers. Some of the company's products are Bare wires, Power cables, Communication cables, Electronic wires & cables, and Enamelled wires. The company's geographical segments are North Asia, Thailand, and Rest of the World.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.